The emerging role of fumarate as an oncometabolite.
The drive to understand how altered cellular metabolism and cancer are linked has caused a paradigm shift in the focus of cancer research. The discovery of a mutated metabolic enzyme, isocitrate dehydrogenase 1, that leads to accumulation of the oncometabolite 2-hydroxyglutarate, provided significan...
Päätekijät: | Yang, M, Soga, T, Pollard, P, Adam, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2012
|
Samankaltaisia teoksia
-
Oncometabolites: linking altered metabolism with cancer.
Tekijä: Yang, M, et al.
Julkaistu: (2013) -
The Emerging Role of LPA as an Oncometabolite
Tekijä: Theodoros Karalis, et al.
Julkaistu: (2024-04-01) -
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
Tekijä: Chowdhury, R, et al.
Julkaistu: (2011) -
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Tekijä: Chowdhury, R, et al.
Julkaistu: (2011) -
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Tekijä: Chowdhury, R, et al.
Julkaistu: (2011)